###begin article-title 0
Cellular and Molecular Bases of the Initiation of Fever
###end article-title 0
###begin article-title 1
Anatomy of a Fever
###end article-title 1
###begin p 2
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 209 210 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 349 350 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 442 443 442 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 677 678 677 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 684 685 684 685 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 949 950 949 950 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1017 1018 1017 1018 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1073 1074 1073 1074 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1127 1128 1127 1128 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1195 1196 1195 1196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1213 1214 1213 1214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1321 1322 1321 1322 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1423 1424 1423 1424 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1480 1481 1480 1481 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 602 606 <span type="species:ncbi:10116">rats</span>
All phases of lipopolysaccharide (LPS)-induced fever are mediated by prostaglandin (PG) E2. It is known that the second febrile phase (which starts at ~1.5 h post-LPS) and subsequent phases are mediated by PGE2 that originated in endotheliocytes and perivascular cells of the brain. However, the location and phenotypes of the cells that produce PGE2 triggering the first febrile phase (which starts at ~0.5 h) remain unknown. By studying PGE2 synthesis at the enzymatic level, we found that it was activated in the lung and liver, but not in the brain, at the onset of the first phase of LPS fever in rats. This activation involved phosphorylation of cytosolic phospholipase A2 (cPLA2) and transcriptional up-regulation of cyclooxygenase (COX)-2. The number of cells displaying COX-2 immunoreactivity surged in the lung and liver (but not in the brain) at the onset of fever, and the majority of these cells were identified as macrophages. When PGE2 synthesis in the periphery was activated, the concentration of PGE2 increased both in the venous blood (which collects PGE2 from tissues) and arterial blood (which delivers PGE2 to the brain). Most importantly, neutralization of circulating PGE2 with an anti-PGE2 antibody both delayed and attenuated LPS fever. It is concluded that fever is initiated by circulating PGE2 synthesized by macrophages of the LPS-processing organs (lung and liver) via phosphorylation of cPLA2 and transcriptional up-regulation of COX-2. Whether PGE2 produced at the level of the blood-brain barrier also contributes to the development of the first phase remains to be clarified.
###end p 2
###begin p 3
The authors show that peripherally-produced COX2 plays an important role in the earliest stages of fever.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b001">1</xref>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b002">2</xref>
###xml 378 379 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b003">3</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b006">6</xref>
###xml 390 391 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 504 505 504 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 510 511 510 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 554 555 554 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 592 593 592 593 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 614 615 614 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 651 652 651 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b006">6</xref>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b007">7</xref>
###xml 684 685 684 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b008">8</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b014">14</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b015">15</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b016">16</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b017">17</xref>
###xml 1204 1205 1204 1205 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 678 682 <span type="species:ncbi:10116">rats</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 1156 1160 <span type="species:ncbi:10116">rats</span>
Fever is an ancient host-defense response and a common symptom of infection and systemic inflammation. Since Milton and Wendlandt [1] discovered the pyrogenic activity of prostaglandins (PGs) of the E series, and Vane [2] found that nonsteroidal anti-inflammatory drugs block fever by inhibiting PG synthesis, it has been accepted that fever is mediated by PGs, specifically PGE2 [3-6]. PGE2 synthesis occurs in three steps: (1) membrane phospholipids are converted to arachidonic acid by phospholipase A2 (PLA2); (2) arachidonic acid is converted to PGH2 by cyclooxygenase (COX); and (3) PGH2 is isomerized to PGE2 by a terminal PGE synthase (PGES) [6,7]. It has been shown in rats [8-14] and mice [15,16] that COX-2 and microsomal PGES-1 (mPGES-1) are transcriptionally up-regulated in endothelial and perivascular cells of brain microvessels between 1.5 and 12 h after administration of pyrogenic doses of bacterial lipopolysaccharide (LPS). Furthermore, Scammell et al. [17] have shown that microinjection of the COX inhibitor ketorolac into the preoptic region attenuates the febrile response over 1.5-6 h after intravenous (i.v.) injection of LPS in rats. These results indicate that febrigenic PGE2 is produced centrally.
###end p 5
###begin p 6
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b018">18</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b019">19</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b019">19</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b020">20</xref>
###xml 771 772 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b021">21</xref>
###xml 781 783 781 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b023">23</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b024">24</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b026">26</xref>
###xml 943 944 943 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1125 1147 1125 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results and Discussion</xref>
###xml 1312 1313 1312 1313 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 262 266 <span type="species:ncbi:10116">rats</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
It should be considered, however, that the initiation of fever precedes by approximately 1 h the earliest time point at which PGE2-synthesizing enzymes have been shown to be up-regulated in the brain. In a thermoneutral environment, i.v. LPS typically causes in rats and mice a polyphasic fever, and the first phase of this response starts at approximately 0.5 h post-LPS [18,19]. Because the first phase is sensitive to ambient temperature and can be readily masked by the stress hyperthermia associated with animal handling and LPS injection [19,20], this phase often escapes detection and remains the least studied component of the febrile response. The first phase of LPS fever was not investigated in any of the abovementioned studies of the source of febrigenic PGE2. We [21-23] and others [24-26] have hypothesized that, unlike the second and subsequent febrile phases, the first phase of fever is triggered by peripherally produced PGE2. Over the last two decades, several studies have attempted to test this hypothesis, but the results obtained have been inconclusive, contradictory, or incomplete (for details, see Results and Discussion). In particular, the location (inside or outside the brain) and phenotypes of the cells involved in the initiation of fever are unknown, as are the steps of the PGE2-synthesizing cascade that are initially activated to trigger the fever response. By closing these gaps, the present study identifies the cellular and molecular bases of the initiation of fever.
###end p 6
###begin title 7
Results/Discussion
###end title 7
###begin p 8
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 176 177 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 185 186 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b024">24</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b027">27</xref>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b024">24</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b028">28</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b029">29</xref>
###xml 545 546 545 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b021">21</xref>
###xml 718 719 718 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 772 773 772 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b030">30</xref>
###xml 583 590 <span type="species:ncbi:9986">rabbits</span>
The question as to whether peripherally (i.v. or intra-arterially) administered PGE2 causes fever remains controversial. Although there are reports of peripherally injected PGE1 and PGE2 being pyrogenic in several species of laboratory animals [24,27], there are at least as many documented failures to induce fever by peripheral administration of PGE [24,28,29]. The latter, negative results can be explained, at least partially, as due to self-aggregation of PGE in aqueous solutions and the subsequent loss of biological activity. Indeed, PGE2 was found to be highly pyrogenic in rabbits when infused in an albumin-bound (monomeric), but not in a free (aggregated) form [21]. Albumin is the principal carrier of PGE2 in the circulation, and up to 99% of circulating PGE2 is albumin-bound [30].
###end p 8
###begin p 9
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 89 90 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 410 411 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 490 491 482 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 603 605 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b031">31</xref>
###xml 691 692 683 684 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 842 844 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b024">24</xref>
###xml 845 847 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b032">32</xref>
###xml 901 902 893 894 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 981 982 973 974 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 984 992 976 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g001">Figure 1</xref>
###xml 1208 1210 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b033">33</xref>
###xml 1336 1337 1328 1329 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 197 203 <span type="species:ncbi:9913">bovine</span>
###xml 369 373 <span type="species:ncbi:10116">rats</span>
###xml 1354 1358 <span type="species:ncbi:10116">rats</span>
In the present study, a 2:1 (molar ratio) PGE2-albumin complex was prepared by adding PGE2 (all reagents are from Sigma-Aldrich, St. Louis, Missouri, United States, unless specified otherwise) and bovine serum albumin (BSA) to pyrogen-free saline, and then sonicating this mixture for 3 min and incubating it at 37 degreesC for 1 h. In a thermoneutral environment, the rats were infused i.v. with BSA-bound PGE2 (280 or 560 mug/kg, 100 mul/kg/min, 10 min). Based on the assumptions that PGE2 is evenly distributed in the extracellular compartment (20% of the body mass) and that its half-life is 1 min [31], it can be estimated that the protocol used elevates the plasma concentration of PGE2 by 350 pg/ml (low dose) or 700 pg/ml (high dose) at 12 min after the beginning of infusion. These concentrations are within the physiological range [24,32]. Whereas BSA had no thermoregulatory effect, the PGE2-BSA complex caused a dose-dependent rise in deep body (colonic) temperature (Tc; Figure 1A). This fever response was brought about, at least in part, by tail skin vasoconstriction, as evident from a decrease in the heat loss index (the quotient of two temperature gradients: skin-ambient/colonic-ambient [33]). Hence, when administered in its most relevant form (albumin complex) and at physiologically relevant doses, peripheral PGE2 is pyrogenic in rats.
###end p 9
###begin p 10
###xml 34 35 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 106 107 106 107 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b034">34</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b035">35</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b036">36</xref>
###xml 373 374 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b037">37</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b038">38</xref>
###xml 545 546 545 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b039">39</xref>
###xml 606 607 606 607 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b006">6</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b026">26</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b040">40</xref>
How circulating, albumin-bound PGE2 causes fever remains speculative. Activation of vagal afferents by PGE2 has been proposed [34], but the fact that vagotomy does not affect the first febrile phase (for discussion, see [35,36]) makes this mechanism unlikely. An alternative scenario seems more plausible. Binding to albumin prevents the rapid enzymatic inactivation of PGE2 [37,38], thus allowing it to reach a distant site. A good candidate for such a site is the preoptic hypothalamus, which is highly sensitive to the pyrogenic effect of PGE2 [39]. Once dissociated from albumin at the target site, PGE2 may be carried into the brain tissue by transporters expressed at the blood-brain barrier (BBB) [6,26,40]. It should be noted, however, that this scenario is speculative and needs to be tested experimentally.
###end p 10
###begin p 11
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 196 212 196 212 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Escherichia coli</named-content>
###xml 355 376 354 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 530 538 529 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g001">Figure 1</xref>
###xml 842 843 841 842 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 941 942 940 941 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1084 1085 1083 1084 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1087 1089 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b039">39</xref>
###xml 1136 1137 1135 1136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1152 1154 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b041">41</xref>
###xml 1173 1174 1172 1173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1268 1276 1267 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g001">Figure 1</xref>
###xml 1339 1340 1338 1339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1487 1488 1486 1487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 50 54 <span type="species:ncbi:10116">rats</span>
###xml 196 212 <span type="species:ncbi:562">Escherichia coli</span>
###xml 309 313 <span type="species:ncbi:10116">rats</span>
###xml 808 812 <span type="species:ncbi:10116">rats</span>
###xml 1262 1266 <span type="species:ncbi:10116">rats</span>
###xml 1395 1399 <span type="species:ncbi:10116">rats</span>
Having shown that peripheral PGE2 is pyrogenic in rats, we asked whether blood levels of PGE2 are elevated at the onset of the first phase of LPS fever. Fever was induced by administering 0111:B4 Escherichia coli LPS (10 mug/kg) nonstressfully via the extension of a preimplanted venous (jugular) catheter to rats kept in a thermoneutral environment (see Materials and Methods for details). The first febrile phase started at approximately 30-min post-LPS and was brought about, at least partially, by tail skin vasoconstriction (Figure 1B). At 40 min (the time corresponding both to the maximal rate of rise in body temperature and to the maximal thermoeffector activity that underlies this rise), samples of venous and arterial blood were collected from LPS-treated (febrile) and saline-treated (afebrile) rats, and the concentration of PGE2 in the venous and arterial blood was measured by enzyme immunoassay. The venous blood gathers PGE2 synthesized in the tissues, and the arterial blood delivers it to the brain, the presumptive site of the febrigenic action of circulating PGE2 [39]. Consistent with the marked catabolism of PGE2 in the lungs [41], the level of PGE2 was lower in the arterial than in the venous blood plasma in both afebrile and febrile rats (Figure 1C). However, both the venous and arterial concentrations of PGE2 were substantially (~2.5 times) higher in the febrile rats as compared to the afebrile controls. These data show that the level of circulating PGE2, most importantly in the arterial blood, is increased at the onset of the first febrile phase.
###end p 11
###begin p 12
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b025">25</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b032">32</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b032">32</xref>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b006">6</xref>
###xml 724 725 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 818 819 818 819 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1063 1064 1063 1064 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1124 1125 1124 1125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1159 1161 1159 1161 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 1163 1165 1163 1165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1263 1269 1263 1265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#945;</sub>
###xml 1277 1278 1273 1274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1295 1296 1291 1292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1301 1307 1297 1299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#945;</sub>
###xml 1316 1317 1308 1309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1367 1368 1359 1360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1591 1593 1582 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b042">42</xref>
###xml 1640 1648 1631 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g002">Figure 2</xref>
###xml 1650 1651 1641 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g002">2</xref>
###xml 1749 1750 1740 1741 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 1845 1853 1836 1844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g002">Figure 2</xref>
###xml 2042 2043 2033 2034 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2177 2185 2168 2176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g002">Figure 2</xref>
###xml 2392 2393 2382 2383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2505 2506 2495 2496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2576 2584 2566 2574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g002">Figure 2</xref>
###xml 2638 2646 2628 2636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g002">Figure 2</xref>
###xml 3169 3177 3159 3167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g002">Figure 2</xref>
###xml 3232 3233 3222 3223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 3480 3481 3470 3471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1080 1087 <span type="species:ncbi:9986">rabbits</span>
###xml 1324 1328 <span type="species:ncbi:10116">rats</span>
###xml 1435 1441 <span type="species:ncbi:9986">rabbit</span>
###xml 2444 2448 <span type="species:ncbi:10116">rats</span>
###xml 2474 2478 <span type="species:ncbi:10116">rats</span>
###xml 3044 3048 <span type="species:ncbi:10116">rats</span>
###xml 3132 3136 <span type="species:ncbi:10116">rats</span>
###xml 3420 3424 <span type="species:ncbi:10116">rats</span>
Several studies aimed at determining the source of febrigenic PGE2 have compared the antipyretic effects of nonsteroidal anti-inflammatory drugs administered peripherally (i.v. or intraperitoneally) and centrally (intracerebroventricularly [i.c.v.]). The drugs used included indomethacin [25], nimesulide [32], and keterolac (present study; unpublished data). All these studies faced multiple methodological problems, including acute thermoregulatory effects of the drug administered i.c.v. (present study), the ability of drugs to cross the BBB, and consequently, their tendency to be distributed evenly between the peripheral compartment and the brain [32]. We proposed [6] that selective neutralization of circulating PGE2 using an antibody is a better approach to test the hypothesis that peripherally produced PGE2 initiates fever. Being large proteins (160 kDa), antibodies cannot cross the BBB; this eliminates uncertainty common in experiments involving nonsteroidal anti-inflammatory drugs. The antibody used in the present study was raised against a PGE2-BSA complex in rabbits. It displayed a high affinity to PGE2 (association constant of 6.3 x 1010 M-1, as determined by Scatchard plot) and a low cross-reactivity with other prostanoids (<15% for PGF1alpha and PGB2, and <9% for PGA2, PGF2alpha, and PGB1). The rats were pretreated i.v. with the anti-PGE2 antibody (neat antiserum; 100 mul/kg/min, 120 min) or with normal rabbit serum, and LPS was injected 18 h later, i.e., at the time when the injected antibody is expected to achieve a steady-state level in the circulation [42]. The results of this experiment are shown in Figure 2A-2C. The antibody (but not normal serum) suppressed the first phase of LPS fever: both the rise in Tc and the associated decrease in the heat loss index were delayed and significantly attenuated (Figure 2A). Immediately after the temperature response was recorded, a sample of venous blood and the whole brain (cleared of blood) were collected for immunoenzymatic determination of the anti-PGE2 antibody. The antibody was found at a high concentration in the blood plasma, but was below the detection limit in the brain tissue (Figure 2C). To rule out the possibility that a minute, undetectable amount of antibody in the brain might have accounted for the suppression of fever, we administered a low dose (2.7 mul/min, 15 min) of the anti-PGE2 antibody or normal serum i.c.v., and injected the rats with LPS 18 h later. The rats injected with the anti-PGE2 antibody i.c.v. had a detectable level of the antibody in the brain (Figure 2C), but their febrile response to LPS was unaffected (Figure 2B). A large fraction of the antibody given i.c.v. leaked into the blood, presumably reflecting the asymmetric nature of the BBB (its major role is to limit transport in the blood-to-brain direction, but not in the opposite direction) or possibly because the BBB was breached in this experimental group by the implanted i.c.v. cannula. Importantly, however, the plasma antibody concentration in the rats treated with the i.c.v. antibody was approximately 60 times lower than that in the rats treated with the i.v. antibody (Figure 2C). It is concluded that minute amounts of the anti-PGE2 antibody in the brain (even when detectable) are not sufficient to suppress the initiation of fever, and that the cause of the delayed and attenuated first febrile phase observed in the rats pretreated with i.v. antibody was neutralization of PGE2 outside the BBB.
###end p 12
###begin p 13
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 156 157 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b022">22</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b022">22</xref>
###xml 728 729 728 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 741 742 737 738 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 785 786 777 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 928 929 920 921 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1040 1042 1032 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b043">43</xref>
###xml 1116 1117 1108 1109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1125 1126 1117 1118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1339 1347 1331 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g001">Figure 1</xref>
###xml 1492 1512 1484 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Material and Methods</xref>
###xml 1666 1674 1658 1666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g003">Figure 3</xref>
###xml 2069 2071 2061 2063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b011">11</xref>
###xml 2072 2074 2064 2066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b012">12</xref>
###xml 2126 2127 2118 2119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2139 2147 2131 2139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g003">Figure 3</xref>
###xml 2202 2210 2194 2202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g004">Figure 4</xref>
###xml 2286 2294 2278 2286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g003">Figure 3</xref>
###xml 2448 2456 2440 2448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g004">Figure 4</xref>
###xml 2621 2622 2613 2614 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2635 2643 2627 2635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g003">Figure 3</xref>
###xml 2782 2784 2762 2764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b044">44</xref>
###xml 2880 2888 2860 2868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g003">Figure 3</xref>
###xml 1333 1337 <span type="species:ncbi:10116">rats</span>
###xml 1617 1621 <span type="species:ncbi:10116">rats</span>
Having demonstrated that circulating PGE2 is indeed responsible, at least partially, for triggering LPS-induced fever, we investigated which step of the PGE2 biosynthetic pathway is activated at the onset of the febrile response. Previously, we reported that the onset of the first phase of LPS fever is associated with large increases of COX-2 and mPGES-1 mRNAs in the lung and liver and with a moderate increase of COX-2 (but not mPGES-1) mRNA in the hypothalamus [22]. However, it remained to be determined whether the observed transcriptional changes translate into changes in the corresponding protein contents at such an early time point (40 min) after LPS administration. We had also shown [22] that neither cytosolic PLA2-alpha (cPLA2-alpha) nor either of the two secretory PLA2 studied (II and V) is transcriptionally up-regulated at the onset of fever. This finding, however, does not exclude the possibility that cPLA2 is activated posttranscriptionally by phosphorylation, the principal mechanism of activation for this enzyme [43]. In the present study, we determined the contents of phosphorylated cPLA2 (p-cPLA2), COX-2, and mPGES-1 proteins by Western blot in the lung, liver, and hypothalamus at 40 min after injection of LPS or saline, a time that corresponds to the onset of the first febrile phase in LPS-treated rats (Figure 1B). COX-2-positive cells were also studied in all three tissues by immunohistochemistry using two different protocols of sample preparation (see Material and Methods). None of the enzymes studied was increased at the protein level in the hypothalamus of the LPS-treated rats as compared to the saline-treated controls (Figure 3). Neither did the immunohistochemical analysis reveal any increase in the number of COX-2-positive hypothalamic cells at the onset of fever, although the same antibody readily detected a surge in the number of COX-2-positive endotheliocytes in the hypothalamic microvasculature at later stages of LPS fever, in both the present study (positive controls; unpublished data) and previous studies [11,12]. In the lung, LPS increased the contents of p-cPLA2 and COX-2 (Figure 3), and augmented the number of cells containing COX-2 (Figure 4), but did not alter the protein level of constitutively expressed mPGES-1 (Figure 3). In the liver, the immunohistochemical analysis (which is more sensitive) revealed a surge in the number of COX-2-positive cells at the onset of fever (Figure 4), whereas the Western blot analysis (less sensitive) found a tendency for an increase in the overall content of COX-2 and no changes in the content of either p-cPLA2 or mPGES-1 (Figure 3). We also found that inflammatory signaling (assessed by a decrease in the content of the nuclear factor-kappaB inhibitor, IkappaB-alpha [44]) was activated in the lung and liver, but not in the hypothalamus, at the onset of LPS fever (Figure 3).
###end p 13
###begin p 14
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 191 192 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 235 236 235 236 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b045">45</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b046">46</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b006">6</xref>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b007">7</xref>
###xml 471 472 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 652 653 652 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 695 696 693 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 743 744 739 740 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 753 754 749 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 836 837 832 833 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1129 1131 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b047">47</xref>
###xml 1123 1127 <span type="species:ncbi:10090">mice</span>
These results show that the onset of the first febrile phase is associated with activation of inflammatory signaling and increased PGE2 synthesis in the periphery. The early activation of PGE2 synthesis involves phosphorylation of cPLA2 (lung) and transcriptional up-regulation of COX-2 (lung and liver). Transcriptional up-regulation is the main (although not the only [45,46]) mechanism of activation for this enzyme [6,7]. Hence, the increased circulating level of PGE2 at the onset of the first febrile phase may be explained by the following enzymatic events in the lung and liver: production of arachidonic acid by activated (phosphorylated) cPLA2 --> conversion of arachidonic acid to PGH2 by up-regulated COX-2 --> isomerization of PGH2 into PGE2 by constitutively expressed mPGES-1. Whereas the physiological importance of cPLA2 and mPGES-1 in the first febrile phase remains to be confirmed in studies with pharmacological or genetic blockade of these enzymes, the indispensable role of COX-2 (and the uninvolvement of COX-1) in the first phase of LPS fever have been demonstrated in our recent study in knockout mice [47].
###end p 14
###begin p 15
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 235 243 235 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g002">Figure 2</xref>
###xml 304 305 304 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 376 377 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b022">22</xref>
###xml 647 654 647 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pbio-0040284-t001">Table 1</xref>
###xml 690 691 690 691 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 802 803 802 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Preferential location of the synthesis of febrigenic PGE2 in the liver and lungs (but not in the brain) deserves special discussion. The fact that the i.v. antibody attenuated the first febrile phase but did not abolish it completely (Figure 2A) may be due to incomplete neutralization of circulating PGE2. However, it may also reflect a contribution of centrally produced PGE2 (e.g., by a small number of hypothalamic cells that express COX-2 constitutively) to the development of the first phase of LPS fever. Although we cannot rule out such a contribution, it is noteworthy that multiple methods used in our present and previous [22] studies (Table 1) found a profound activation of PGE2 synthesis in the periphery, but hardly any signs (none at the protein level) of activation of hypothalamic PGE2 synthesis.
###end p 15
###begin p 16
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b048">48</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b049">49</xref>
###xml 958 966 958 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g004">Figure 4</xref>
###xml 1530 1532 1522 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b050">50</xref>
To identify the pulmonary and hepatic producers of PGE2, we first determined how the cells that become COX-2 positive at the onset of LPS fever relate to the histological elements revealed by eosin staining; this analysis was performed in freshly frozen samples. In the lung, COX-2-positive cells were found to cluster around alveoli, often forming what looked like cell chains (unpublished data). In the liver, the parenchyma did not stain for COX-2, and the vast majority of COX-2-positive cells were located in the stromal compartment, often in close proximity to sinusoids. Some COX-2-positive cells were also found around the central vein (a small vein that gathers the blood from sinusoids) and in the visceral peritoneum covering the liver (unpublished data). We then double-stained lung and liver for COX-2 and either the macrophage marker ED2 [48] or the endothelial marker RECA1 [49]; this analysis was performed in paraformaldehyde-fixed samples (Figure 4). In the lung, 89 +/- 6% (mean +/- standard error [SE] of five samples) of COX-2-positive cells were macrophages (ED2 positive), and 11% were unidentified (ED2 and RECA1 negative). In the liver, 83 +/- 2% of the COX-2-positive cells were macrophages (ED2 positive), 9 +/- 1% were endotheliocytes (RECA1 positive), and 8% remained unidentified. The key role of macrophages in the initiation of fever agrees with our recent finding that the first febrile phase depends entirely on the recognition of LPS (via the Toll-like receptor-4) by bone marrow-derived cells [50].
###end p 16
###begin p 17
###xml 110 111 110 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 168 169 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 257 258 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 360 359 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 627 628 627 628 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In summary, the present study shows that the first phase of LPS fever is initiated (at least partially) by PGE2 that originated in peripheral tissues. Activation of PGE2 synthesis at the onset of the first phase of LPS fever involves phosphorylation of cPLA2, transcriptional up-regulation of COX-2, and possibly other mechanisms. The vast majority of the PGE2-producing cells are macrophages. These findings challenge the predominant view that fever is initiated exclusively by inflammatory mediators produced at the level of the BBB. These findings, however, do not contradict the principal role of the centrally produced PGE2 in the second and subsequent febrile phases.
###end p 17
###begin title 18
Materials and Methods
###end title 18
###begin title 19
Animals.
###end title 19
###begin p 20
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b020">20</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b022">22</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b023">23</xref>
###xml 43 47 <span type="species:ncbi:10116">rats</span>
###xml 130 134 <span type="species:ncbi:10116">rats</span>
###xml 225 228 <span type="species:ncbi:10116">rat</span>
###xml 360 363 <span type="species:ncbi:10116">rat</span>
The study was conducted in male Long-Evans rats weighing 300-400 g (Charles River, Wilmington, Massachusetts, United States). The rats were habituated (seven daily training sessions, 4 h each) to spending time in artificial "rat holes," cylindrical confiners made of stainless steel wire [20,22,23]. The same confiners were used later in the experiments. Each rat was used in only one experiment. The protocols were approved by the St. Joseph's Hospital Animal Care and Use Committee.
###end p 20
###begin title 21
Surgery and instrumentation.
###end title 21
###begin p 22
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b022">22</xref>
###xml 550 551 550 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 182 185 <span type="species:ncbi:10116">rat</span>
###xml 442 445 <span type="species:ncbi:10116">rat</span>
###xml 1054 1058 <span type="species:ncbi:10116">rats</span>
Under ketamine-xylazine-acepromazine anesthesia (55.6, 5.5, and 1.1 mg/kg, respectively, intraperitoneally) and antibiotic (enrofloxacin, 1.1 mg/kg, subcutaneously) protection, each rat was subjected to chronic catheterization of the jugular vein as described elsewhere [22]. The catheters were flushed with heparinized (10 U/ml) saline on Days 1 and 3 postsurgery. The experiments were performed on Day 5. On the day of the experiment, each rat was placed in a wire confiner and equipped with two copper-constantan thermocouples: one for recording Tc and the other for recording tail skin temperature. The colonic thermocouple was inserted 10 cm beyond the anal sphincter and fixed to the base of the tail with adhesive tape. The skin thermocouple was positioned at the boundary of the proximal and middle thirds of the tail, on its lateral surface, and was insulated from the environment with tape. The thermocouples were plugged in to a data logger (Cole-Parmer, Vernon Hills, Illinois, United States), which was connected to a personal computer. The rats in their confiners were placed in a climatic chamber (Forma Scientific, Marietta, Ohio, United States) set to a neutral ambient temperature of 30.0 degreesC. Their jugular catheters were extended with lengths of PE-50 tubing filled with saline, thus permitting i.v. drug administration to be performed in a stress-free fashion, from outside the chamber.
###end p 22
###begin title 23
Tissue harvesting.
###end title 23
###begin p 24
###xml 484 486 483 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g,</italic>
###xml 65 69 <span type="species:ncbi:10116">rats</span>
Immediately before collection of blood and tissue specimens, the rats were anesthetized with ketamine-xylazine-acepromazine (5.56, 0.55, and 0.11 mg/kg, respectively, i.v.). Blood samples were collected either from the inferior vena cava (venous blood) or left ventricle (arterial blood). Each sample was transferred to an eppendorf tube containing EDTA and indomethacin (final concentrations: 1 mg/ml and 10 muM, respectively). The collected blood was immediately centrifuged (3,000 g, 10 min, 4 degreesC), and the resulting plasma was stored at -80 degreesC.
###end p 24
###begin p 25
###xml 86 89 <span type="species:ncbi:10116">rat</span>
For collection of tissue samples for the immunoassay and Western blot protocols, each rat was perfused through the left ventricle (right atrium cut) with 100 ml of 10 mM phosphate-buffered saline (PBS; pH 7.4). The right medial lobe of the liver, the medial lobe of the right lung, and either the hypothalamus (for Western blot) or the entire brain were collected rapidly and snap frozen in liquid nitrogen. The samples were stored at -80 degreesC.
###end p 25
###begin p 26
###xml 164 167 <span type="species:ncbi:10116">rat</span>
###xml 447 450 <span type="species:ncbi:10116">rat</span>
Tissue specimens for the immunohistochemistry protocols were collected using two methods. For immunohistochemical analysis of freshly frozen (non-fixed) tissues, a rat was perfused with PBS (50 ml). The liver, right lung, and brain were excised, frozen in dry ice powder, and stored at -80 degreesC. The specimens were cryosectioned (section thickness, 14 mum) immediately before the analysis. For immunohistochemical analysis of fixed tissues, a rat was perfused with 50 ml of heparinized (10 U/ml) PBS followed by 200 ml of a 4% paraformaldehyde solution in PBS. The liver, right lung, and brain were excised, postfixed in the paraformaldehyde solution for 2 h, transferred to PBS containing 20% sucrose, and kept in this solution at 4 degreesC for 24 h. The specimens were then frozen, cryosectioned (section thickness, 30 mum), and immediately subjected to the immunohistochemical analysis.
###end p 26
###begin title 27
Immunoassays.
###end title 27
###begin p 28
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 225 226 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 438 439 438 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 473 474 473 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 970 972 970 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g,</italic>
###xml 335 339 <span type="species:ncbi:9925">goat</span>
###xml 345 350 <span type="species:ncbi:10090">mouse</span>
###xml 400 405 <span type="species:ncbi:10090">mouse</span>
###xml 411 417 <span type="species:ncbi:9986">rabbit</span>
###xml 423 429 <span type="species:ncbi:9986">rabbit</span>
###xml 475 486 <span type="species:ncbi:3704">horseradish</span>
PGE2 was measured in plasma by enzyme immunoassay using a commercially available kit (Cayman, Ann Arbor, Michigan, United States); the samples were prepared according to the manufacturer's instructions. The levels of anti-PGE2 antibody in the plasma and brain were assayed by enzyme immunoassay involving a conjugate of four proteins: goat anti-mouse IgG (which coated all wells of a 96-well plate), mouse anti-rabbit IgG, rabbit anti-PGE2 IgG (sample or standard), and PGE2-horseradish peroxidase complex (Amersham, Piscataway, New Jersey, United States). The conjugate was developed by adding the peroxidase substrate 3,3',5,5'-tetramethylbenzidine; the reaction product had maximal absorbance at 630 nm. Samples of blood plasma were diluted (1:256) in 100 mM Tris-buffered saline (pH 7.4) before the assay. Each brain was homogenized in 4 ml of a 100 mM NaOH solution containing 0.2% sodium dodecyl sulfate. After the homogenate was cleared by centrifugation (14,000 g, 10 min, 6 degreesC), the supernatant was neutralized with 100 mM HCl and diluted (1:10) with Tris-buffered saline. The detection limits for blood plasma (4 mug/g) and brain tissue (1 mug/g) were determined as the triple noise-level concentrations.
###end p 28
###begin title 29
Western blot.
###end title 29
###begin p 30
###xml 115 117 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b051">51</xref>
###xml 160 161 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 390 391 368 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 648 649 615 616 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 205 211 <span type="species:ncbi:9986">rabbit</span>
The Western blot protocol was identical to that used to measure IkappaB-alpha and beta-actin in our earlier study [51], except that here we also measured p-cPLA2, COX-2, and mPGES-1. The following primary rabbit polyclonal antibodies were used (dilutions indicated): anti-IkappaB-alpha (1:1,000; Cell Signaling, Beverly, Massachusetts, United States), anti-beta-actin (1:1,000), anti-p-cPLA2 (1:500; Cell Signaling), anti-COX-2 (1:1,000; Cayman), and anti-mPGES-1 (1:1,000; Cayman). The primary antibodies revealed immunoblot bands corresponding to the following molecular masses: 36 kDa for IkappaB-alpha; 42 kDa for beta-actin; 105 kDa for p-cPLA2; 72 kDa for COX-2; and 16 kDa for mPGES-1.
###end p 30
###begin title 31
Immunohistochemistry.
###end title 31
###begin p 32
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b011">11</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b012">12</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b052">52</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b052">52</xref>
###xml 675 676 672 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Single immunofluorescence was used to visualize and localize COX-2-positive cells in freshly frozen [11,12] or paraformaldehyde-fixed [52] samples of lung, liver, and hypothalamus. Dual immunofluorescence protocols were used to verify co-localization of COX-2 with ED2 (a macrophage marker) or RECA1 (an endotheliocyte marker) in paraformaldehyde-fixed samples of lung and liver [52]. The fraction of COX-2-immunoreactive cells that were also immunoreactive to ED2 or RECA1 was determined in serial (10-15) sections (30 mum-thick) collected at 150-mum intervals through the right lobe of the liver or right lung. Images of merged confocal channels were collected from 104-mum2 fields (nine for each section).
###end p 32
###begin title 33

###end title 33
###begin p 34
Technical assistance of D. L. Oliveira is appreciated.
###end p 34
###begin p 35
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. AAS, AII, SK, KM, PES, and AAR conceived and designed the experiments. AAS, AII, JS, HH, ANP, JRR, and JLR performed the experiments. AAS, AAI, JS, HH, ANP, SK, KM, PES, and AAR analyzed the data. AAS and AAR wrote the paper.
###end p 35
###begin p 36
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. The study was funded by the National Institutes of Health (grants NS41233 to AAR and NS21182 to PES) and Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan (KM). Additional funding was provided by the St. Joseph's Foundation and Sigma-Aldrich Corporation.
###end p 36
###begin p 37
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 37
###begin title 38
Abbreviations
###end title 38
###begin p 39
blood-brain barrier
###end p 39
###begin p 40
###xml 0 6 <span type="species:ncbi:9913">bovine</span>
bovine serum albumin
###end p 40
###begin p 41
cyclooxygenase
###end p 41
###begin p 42
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
cytosolic phospholipase A2
###end p 42
###begin p 43
intracerebroventricular(ly)
###end p 43
###begin p 44
intravenous(ly)
###end p 44
###begin p 45
lipopolysaccharide
###end p 45
###begin p 46
microsomal prostaglandin E synthase
###end p 46
###begin p 47
phosphate-buffered saline
###end p 47
###begin p 48
###xml 40 41 40 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
phosphorylated cytosolic phospholipase A2
###end p 48
###begin p 49
prostaglandin
###end p 49
###begin p 50
phospholipase A2
###end p 50
###begin p 51
###xml 17 18 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
standard error, Tc, colonic temperature
###end p 51
###begin title 52
References
###end title 52
###begin article-title 53
###xml 35 36 35 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 116 119 <span type="species:ncbi:9685">cat</span>
A possible role for prostaglandin E1 as a modulator for temperature regulation in the central nervous system of the cat
###end article-title 53
###begin article-title 54
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
###end article-title 54
###begin article-title 55
Mechanisms of CNS response to systemic immune challenge: The febrile response
###end article-title 55
###begin article-title 56
Prostaglandins as inflammatory messengers across the blood-brain barrier
###end article-title 56
###begin article-title 57
Signaling the brain in inflammation: The role of endothelial cells
###end article-title 57
###begin article-title 58
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Prostaglandin E2 as a mediator of fever: Synthesis and catabolism
###end article-title 58
###begin article-title 59
###xml 74 75 74 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway
###end article-title 59
###begin article-title 60
###xml 94 97 <span type="species:ncbi:10116">rat</span>
Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain
###end article-title 60
###begin article-title 61
###xml 81 84 <span type="species:ncbi:10116">rat</span>
Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages
###end article-title 61
###begin article-title 62
Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: Light and electron microscopic immunocytochemical studies
###end article-title 62
###begin article-title 63
###xml 109 113 <span type="species:ncbi:10116">rats</span>
Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever
###end article-title 63
###begin article-title 64
###xml 55 56 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Brain-specific endothelial induction of prostaglandin E2 synthesis enzymes and its temporal relation to fever
###end article-title 64
###begin article-title 65
###xml 114 117 <span type="species:ncbi:10116">rat</span>
Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain
###end article-title 65
###begin article-title 66
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: Relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli
###end article-title 66
###begin article-title 67
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2-/-, but not in cyclooxygenase-1-/- mice
###end article-title 67
###begin article-title 68
Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis
###end article-title 68
###begin article-title 69
Microinjection of a cyclooxygenase inhibitor into the anteroventral preoptic region attenuates LPS fever
###end article-title 69
###begin article-title 70
"Biphasic" fevers often consist of more than two phases
###end article-title 70
###begin article-title 71
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Thermoregulatory responses to lipopolysaccharide in the mouse: Dependence on the dose and ambient temperature
###end article-title 71
###begin article-title 72
Methodology of fever research: Why are polyphasic fevers often thought to be biphasic?
###end article-title 72
###begin article-title 73
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Blood-borne, albumin-bound prostaglandin E2 may be involved in fever
###end article-title 73
###begin article-title 74
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Prostaglandin E2-synthesizing enzymes in fever: Differential transcriptional regulation
###end article-title 74
###begin article-title 75
###xml 130 131 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Albumin is not an irreplaceable carrier for amphipathic mediators of thermoregulatory responses to LPS: compensatory role of alpha1-acid glycoprotein
###end article-title 75
###begin article-title 76
Role of prostaglandin E in the biphasic fever response to endotoxin
###end article-title 76
###begin article-title 77
###xml 110 117 <span type="species:ncbi:9986">rabbits</span>
Evidence for separate mechanisms of induction of biphasic fever inside and outside the blood-brain barrier in rabbits
###end article-title 77
###begin article-title 78
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cytokines and cytokine inducers stimulate prostaglandin E2 entry into the brain
###end article-title 78
###begin article-title 79
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 150 154 <span type="species:ncbi:10116">rats</span>
Central action of prostaglandin E2 and its methyl ester in the induction of hyperthermia after their systemic administration in urethane-anesthetized rats
###end article-title 79
###begin article-title 80
###xml 128 132 <span type="species:ncbi:9685">cats</span>
###xml 137 144 <span type="species:ncbi:9986">rabbits</span>
Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanaesthetized cats and rabbits
###end article-title 80
###begin article-title 81
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 94 101 <span type="species:ncbi:9986">rabbits</span>
Effects of intravenous and intraventricular prostaglandin E1 on thermoregulatory responses in rabbits
###end article-title 81
###begin article-title 82
###xml 28 33 <span type="species:ncbi:9606">human</span>
Binding of prostaglandin to human serum albumin
###end article-title 82
###begin article-title 83
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 36 40 <span type="species:ncbi:9685">cats</span>
Elimination from the circulation of cats of 6-keto-prostaglandin E1 compared with prostaglandins E2 and I2
###end article-title 83
###begin article-title 84
###xml 132 143 <span type="species:ncbi:10141">guinea pigs</span>
Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs
###end article-title 84
###begin article-title 85
###xml 62 66 <span type="species:ncbi:10116">rats</span>
Selected contribution: Ambient temperature for experiments in rats: A new method for determining the zone of thermal neutrality
###end article-title 85
###begin article-title 86
Activation of vagal afferents after intravenous injection of interleukin-1beta: Role of endogenous prostaglandins
###end article-title 86
###begin article-title 87
Lipopolysaccharide fever is initiated via a capsaicin-sensitive mechanism independent of the subtype-1 vanilloid receptor
###end article-title 87
###begin article-title 88
Signaling the brain in the early sickness syndrome: Are sensory nerves involved?
###end article-title 88
###begin article-title 89
Effects of binding of amphipathic compounds to carrier proteins on their enzymic biotransformation by membrane-bound enzymes
###end article-title 89
###begin article-title 90
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Ventromedial preoptic prostaglandin E2 activates fever-producing autonomic pathways
###end article-title 90
###begin article-title 91
Effects of LPS stimulation on the expression of prostaglandin carriers in the cells of the blood-brain and blood-cerebrospinal fluid barriers
###end article-title 91
###begin article-title 92
Inactivation of prostaglandins by the lungs
###end article-title 92
###begin article-title 93
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo
###end article-title 93
###begin article-title 94
###xml 4 5 4 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
cPLA2 is phosphorylated and activated by MAP kinase
###end article-title 94
###begin article-title 95
The NF-kB and IkB proteins: New discoveries and insights
###end article-title 95
###begin article-title 96
Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells
###end article-title 96
###begin article-title 97
###xml 76 79 <span type="species:ncbi:10116">rat</span>
Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds
###end article-title 97
###begin article-title 98
Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses
###end article-title 98
###begin article-title 99
###xml 106 109 <span type="species:ncbi:10116">rat</span>
The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3
###end article-title 99
###begin article-title 100
###xml 20 23 <span type="species:ncbi:10116">rat</span>
Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody
###end article-title 100
###begin article-title 101
Bacterial lipopolysaccharide fever is initiated via Toll-like receptor 4 on hematopoietic cells
###end article-title 101
###begin article-title 102
A new function of the leptin receptor: mediation of the recovery from lipopolysaccharide-induced hypothermia
###end article-title 102
###begin article-title 103
Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults
###end article-title 103
###begin title 104
Figures and Tables
###end title 104
###begin title 105
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 40 44 <span type="species:ncbi:10116">Rats</span>
Circulating PGE2 Initiates LPS Fever in Rats: Circumstantial Evidence
###end title 105
###begin p 106
###xml 66 67 66 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 79 80 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 104 108 <span type="species:ncbi:10116">rats</span>
(A) The effects of i.v. infusion (horizontal bar) of BSA-bound PGE2 or BSA on Tc and heat loss index of rats kept at a neutral ambient temperature (30 degreesC).
###end p 106
###begin p 107
(B) The effects of i.v. bolus injection (arrow) of LPS or saline on the same parameters.
###end p 107
###begin p 108
###xml 11 12 11 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 48 49 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 156 157 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 333 334 309 310 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 367 368 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 679 681 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio-0040284-b033">33</xref>
Change in Tc was calculated by subtracting the Tc value at a given point from that at the start of infusion or injection (time zero). In (A), the absolute Tcs at time zero were 38.3 +/- 0.1 degreesC, 38.5 +/- 0.1 degreesC, and 38.4 +/- 0.2 degreesC for the groups treated with BSA and with the lower and higher doses of BSA-bound PGE2, respectively. In (B), initial Tcs were 38.2 +/- 0.1 degreesC and 38.3 +/- 0.1 degreesC for the groups treated with saline and LPS, respectively. The heat loss index was calculated as a quotient of two temperature gradients: skin-ambient and colonic-ambient; this index varies between 0 (maximal vasoconstriction) and 1 (maximal vasodilation) [33].
###end p 108
###begin p 109
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 366 369 364 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(n)</italic>
###xml 474 475 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 586 587 584 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 59 63 <span type="species:ncbi:10116">rats</span>
###xml 347 351 <span type="species:ncbi:10116">rats</span>
(C) The levels of PGE2 in the venous and arterial blood of rats 40 min after i.v. injection of LPS or saline at thermoneutrality. This time point corresponds to the maximal thermoeffector activity (minimal heat loss index) to produce the first phase of LPS fever as shown in (B). All doses are indicated. Means +/- SE are presented. The number of rats in each group (n) is indicated. An asterisk (*) indicates a significant difference from the BSA- or saline-treated group (p < 0.05; two-way analysis of variance for repeated measures followed by the Tukey test in [A] and [B]; Student t-test in [C]).
###end p 109
###begin title 110
###xml 15 16 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 40 44 <span type="species:ncbi:10116">Rats</span>
Circulating PGE2 Initiates LPS Fever in Rats: Direct Evidence
###end title 110
###begin p 111
###xml 74 75 73 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 151 152 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 186 190 <span type="species:ncbi:10116">rats</span>
(A) The effects of i.v. infusion (100 mul/kg/min, 120 min) of the anti-PGE2 antibody or normal serum 18 h before the experiment (pretreatment) on the Tc and heat loss index responses of rats injected (arrow) with LPS at thermoneutrality (30 degreesC).
###end p 111
###begin p 112
###xml 81 82 80 81 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 382 383 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
(B) The effects of the i.c.v. infusion (2.7 mul/min, 15 min) of the same anti-PGE2 antibody or normal serum 18 h before the experiment (pretreatment) on the same responses. Note that the i.c.v. infusion was aimed at testing whether minute amounts of the antibody in the brain are sufficient to suppress LPS fever (and not at testing whether fever is altered by neutralization of PGE2 in the brain).
###end p 112
###begin p 113
###xml 11 12 11 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 48 49 48 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 143 144 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
###xml 307 308 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sub>
Change in Tc was calculated by subtracting the Tc value at a given point from that at the time of injection (time zero). In (A), the absolute Tcs at time zero were 38.2 +/- 0.1 degreesC and 38.1 +/- 0.2 degreesC for the groups treated with i.v. normal serum and antibody, respectively. In (B), the initial Tcs were 38.4 +/- 0.1 degreesC and 38.2 +/- 0.2 degreesC for the groups treated with i.c.v. normal serum and antibody, respectively.
###end p 113
###begin p 114
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 474 477 472 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(n)</italic>
###xml 589 590 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 76 80 <span type="species:ncbi:10116">rats</span>
###xml 455 459 <span type="species:ncbi:10116">rats</span>
(C) The levels of anti-PGE2 antibody in the blood plasma and whole brain of rats pretreated with i.v. or i.c.v. antibody. Blood samples and brains were collected immediately after the temperature responses were recorded, i.e., approximately 20 h after pretreatment with the antibody. Antibody levels (means +/- SE) are expressed as microgram of neat antibody per gram of either plasma or brain tissue. The detection limit for each assay and the number of rats in each group (n) are indicated. An asterisk (*) indicates a significant difference from the group pretreated with normal serum (p < 0.05; two-way analysis of variance for repeated measures followed by the Tukey test).
###end p 114
###begin title 115
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 71 75 <span type="species:ncbi:10116">Rats</span>
Mechanism of Activation of PGE2 Synthesis at the Onset of LPS Fever in Rats
###end title 115
###begin p 116
###xml 117 118 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 147 148 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 523 531 507 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio-0040284-g001">Figure 1</xref>
###xml 759 762 738 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(n)</italic>
###xml 870 871 849 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 888 889 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 754 758 <span type="species:ncbi:10116">rats</span>
Tissue contents of the following proteins are shown: IkappaB-alpha (an inhibitor of nuclear factor-kappaB), three PGE2-synthesizing enzymes (p-cPLA2, COX-2, and mPGES-1), and beta-actin (a "housekeeping" protein). These proteins were determined by Western blot in the lung, liver, and hypothalamus. The tissue samples were collected 40 min after i.v. injection of LPS (10 mug/kg) or saline at thermoneutrality. This time point corresponds to the maximal thermoeffector activity to produce the first phase of LPS fever (see Figure 1B). Electrophoretograms of two representative animals from each group are shown on top. The expression of each protein of interest (relative to the expression of beta-actin) is shown on bottom (means +/- SE); the number of rats (n) is shown in parenthesis. An asterisk (*) indicates a significant difference from the saline-treated group (p < 0.05; Student t-test).
###end p 116
###begin title 117
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 94 98 <span type="species:ncbi:10116">Rats</span>
Identification of the Pulmonary and Hepatic Cells Producing PGE2 at the Onset of LPS Fever in Rats
###end title 117
###begin p 118
###xml 201 205 <span type="species:ncbi:10116">rats</span>
Immunolocalization of COX-2 in the lung and liver and identification of the cell types expressing this enzyme. Top row: tissue localization of COX-2 (green immunofluorescence) in the lung and liver of rats at 40 min after i.v. injection of saline or at the onset of the first febrile phase (i.e., 40 min after i.v. injection of LPS, 10 mug/kg) at thermoneutrality. Next rows: dual localization of LPS-induced COX-2-immunoreactivity (green; left column) with either the macrophage marker ED2 or the endothelial cell marker RECA1 (red; middle column) in the lung and liver at the onset of the first febrile phase. Doubly labeled cells appear yellow in the merged confocal images (right column). White arrows and black arrowheads mark examples of doubly and singly (COX-2 only) labeled cells, respectively. Scale bars represent 40 mum.
###end p 118
###begin p 119
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Inflammatory Signaling and PGE2 Synthesis Are Selectively Activated at the Onset of the First Phase of LPS Fever in the Periphery (Lung and Liver) but Not in the Brain (Hypothalamus)
###end p 119

